Karyopharm Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Selinexor as a Treatment for Patients with Penta-Refractory Multiple Myeloma Pharmaceutical Investing
Moleculin Expects to Meet FDA IND Filing Requirements for its Pancreatic Cancer Drug Candidate with Development Work in Australia Pharmaceutical Investing
Athenex Announces Axis Therapeutics Enters into MOU with Hong Kong Polytechnic University Biotech Investing
Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C Pharmaceutical Investing
CytoDyn Announces Positive Results from Completed Pivotal PRO 140 HIV Combination Trial Biotech Investing
Aequus Extends and Enhances Commercial Agreement to Promote Vistitan in Canada Pharmaceutical Investing
